Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer’s disease

Fig. 3

Comparison of unweighted (i.e., average of MEM/LAN/EF/VS) and tau-PET-informed personalized cognitive composites for AD-spectrum patients (i.e., Aβ+) within the ADNI cohort (A) and the A05 cohort (B). Statistics were derived from paired t-tests. The model for the tau-PET-informed personalized cognitive composites was controlled for age, sex, clinical status, and APOE4 status

Back to article page